These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 9585022)

  • 41. Screening for colorectal cancer with immunochemical faecal occult blood tests.
    Faivre J; Dancourt V; Lejeune C
    Dig Liver Dis; 2012 Dec; 44(12):967-73. PubMed ID: 22898146
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Interval cancers in a guaiac-based colorectal cancer screening programme: Consequences on sensitivity.
    Blom J; Törnberg S
    J Med Screen; 2017 Sep; 24(3):146-152. PubMed ID: 28142309
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A randomised study of screening for colorectal cancer using faecal occult blood testing: results after 13 years and seven biennial screening rounds.
    Jørgensen OD; Kronborg O; Fenger C
    Gut; 2002 Jan; 50(1):29-32. PubMed ID: 11772963
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Screening for colorectal cancer by immunochemical fecal occult blood testing.
    Saito H
    Jpn J Cancer Res; 1996 Oct; 87(10):1011-24. PubMed ID: 8957057
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Colorectal cancer mortality: effectiveness of biennial screening for fecal occult blood.
    Mandel JS; Church TR; Ederer F; Bond JH
    J Natl Cancer Inst; 1999 Mar; 91(5):434-7. PubMed ID: 10070942
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Screening for colorectal neoplasias with fecal occult blood tests: false-positive impact of non-dietary restriction.
    Roslani AC; Abdullah T; Arumugam K
    Asian Pac J Cancer Prev; 2012; 13(1):237-41. PubMed ID: 22502676
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Cost analysis in a population based screening programme for colorectal cancer: comparison of immunochemical and guaiac faecal occult blood testing.
    Castiglione G; Zappa M; Grazzini G; Sani C; Mazzotta A; Mantellini P; Ciatto S
    J Med Screen; 1997; 4(3):142-6. PubMed ID: 9368871
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Comparison between a guaiac and three immunochemical faecal occult blood tests in screening for colorectal cancer.
    Faivre J; Dancourt V; Denis B; Dorval E; Piette C; Perrin P; Bidan JM; Jard C; Jung S; Levillain R; Viguier J; Bretagne JF
    Eur J Cancer; 2012 Nov; 48(16):2969-76. PubMed ID: 22572481
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Sensitivity of immunochemical occult blood testing in detecting early colorectal cancer].
    Saito H
    Nihon Rinsho; 1996 May; 54(5):1421-4. PubMed ID: 8965378
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Comparison of a brush-sampling fecal immunochemical test for hemoglobin with a sensitive guaiac-based fecal occult blood test in detection of colorectal neoplasia.
    Smith A; Young GP; Cole SR; Bampton P
    Cancer; 2006 Nov; 107(9):2152-9. PubMed ID: 16998938
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Diagnostic yield of a one sample immunochemical test at different cut-off values in an organised screening programme for colorectal cancer.
    Hamza S; Dancourt V; Lejeune C; Bidan JM; Lepage C; Faivre J
    Eur J Cancer; 2013 Aug; 49(12):2727-33. PubMed ID: 23601670
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Use of faecal markers in screening for colorectal neoplasia: a European group on tumor markers position paper.
    Duffy MJ; van Rossum LG; van Turenhout ST; Malminiemi O; Sturgeon C; Lamerz R; Nicolini A; Haglund C; Holubec L; Fraser CG; Halloran SP
    Int J Cancer; 2011 Jan; 128(1):3-11. PubMed ID: 20824704
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Random comparison of guaiac and immunochemical fecal occult blood tests for colorectal cancer in a screening population.
    van Rossum LG; van Rijn AF; Laheij RJ; van Oijen MG; Fockens P; van Krieken HH; Verbeek AL; Jansen JB; Dekker E
    Gastroenterology; 2008 Jul; 135(1):82-90. PubMed ID: 18482589
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Screening for colorectal cancer with an immunological faecal occult blood test: 2-year follow-up.
    Robinson MH; Marks CG; Farrands PA; Bostock K; Hardcastle JD
    Br J Surg; 1996 Apr; 83(4):500-1. PubMed ID: 8665240
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Short term outcomes of the first round of a pilot colorectal cancer screening programme with guaiac based faecal occult blood test.
    Denis B; Ruetsch M; Strentz P; Vogel JY; Guth F; Boyaval JM; Pagnon X; Ebelin JF; Gendre I; Perrin P
    Gut; 2007 Nov; 56(11):1579-84. PubMed ID: 17616542
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Stool DNA and occult blood testing for screen detection of colorectal neoplasia.
    Ahlquist DA; Sargent DJ; Loprinzi CL; Levin TR; Rex DK; Ahnen DJ; Knigge K; Lance MP; Burgart LJ; Hamilton SR; Allison JE; Lawson MJ; Devens ME; Harrington JJ; Hillman SL
    Ann Intern Med; 2008 Oct; 149(7):441-50, W81. PubMed ID: 18838724
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A systematic review of the effects of screening for colorectal cancer using the faecal occult blood test, hemoccult.
    Towler B; Irwig L; Glasziou P; Kewenter J; Weller D; Silagy C
    BMJ; 1998 Aug; 317(7158):559-65. PubMed ID: 9721111
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A case-control study evaluating occult blood screening for colorectal cancer with hemoccult test and an immunochemical hemagglutination test.
    Saito H; Soma Y; Nakajima M; Koeda J; Kawaguchi H; Kakizaki R; Chiba R; Aisawa T; Munakata A
    Oncol Rep; 2000; 7(4):815-9. PubMed ID: 10854550
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Comparison of a New-generation Fecal Immunochemical Test (FIT) With Guaiac Fecal Occult Blood Test (gFOBT) in Detecting Colorectal Neoplasia Among Colonoscopy-referral Patients.
    Guimarães DP; Fregnani JH; Reis RM; Taveira LN; Scapulatempo-Neto C; Matsushita M; Silva SRM; Oliveira CZ; Longatto-Filho A; Eklund C; Paloheimo L; Mauad E; Suovaniemi O; Syrjänen K
    Anticancer Res; 2019 Jan; 39(1):261-269. PubMed ID: 30591467
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Colonoscopy as a mass screening tool.
    Lieberman D
    Eur J Gastroenterol Hepatol; 1998 Mar; 10(3):225-8. PubMed ID: 9585025
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.